Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Grifols, S.A Gross Profit 2012-2024 | GRFS

Grifols, S.A gross profit from 2012 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  
Grifols, S.A Annual Gross Profit
(Millions of US $)
2023 $2,700
2022 $2,351
2021 $2,322
2020 $2,576
2019 $2,622
2018 $2,421
2017 $2,432
2016 $2,116
2015 $2,144
2014 $2,259
2013 $1,883
2012 $1,710
2011 $1,900
Grifols, S.A Quarterly Gross Profit
(Millions of US $)
2024-06-30 $722
2023-09-30 $662
2023-06-30 $674
2023-03-31 $595
2022-06-30 $615
2021-06-30 $700
2019-06-30 $672
2018-06-30 $617
2017-06-30 $617
2017-03-31 $578
2016-12-31 $543
2016-09-30 $522
2016-06-30 $528
2016-03-31 $523
2015-12-31 $572
2015-09-30 $537
2015-06-30 $526
2015-03-31 $506
2014-12-31 $442
2014-09-30 $567
2014-06-30 $532
2014-03-31 $594
2013-12-31 $456
2013-09-30 $471
2013-06-30 $485
2013-03-31 $462
2012-12-31 $421
2012-09-30 $418
2012-06-30 $430
2012-03-31 $423
2011-12-31 $796
2011-09-30 $807
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $7.134B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $88.259B 35.16
Takeda Pharmaceutical (TAK) Japan $46.264B 9.26
Merck (MKGAF) Germany $22.763B 24.84
Astellas Pharma (ALPMY) Japan $21.481B 25.80
Sandoz Group AG (SDZNY) Switzerland $18.033B 0.00
United Therapeutics (UTHR) United States $15.951B 16.48
Summit Therapeutics (SMMT) United States $15.132B 0.00
Shionogi (SGIOY) Japan $13.190B 12.64
Neurocrine Biosciences (NBIX) United States $11.618B 34.76
Catalent (CTLT) United States $10.948B 0.00
Orion OYJ (ORINY) Finland $8.028B 32.69
Revolution Medicines (RVMD) United States $7.378B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.850B 7.26
Ionis Pharmaceuticals (IONS) United States $5.973B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.612B 0.00
Corcept Therapeutics (CORT) United States $4.590B 38.88
Crinetics Pharmaceuticals (CRNX) United States $4.062B 0.00
Dyne Therapeutics (DYN) United States $3.397B 0.00
PTC Therapeutics (PTCT) United States $2.889B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.535B 14.62
Arrowhead Pharmaceuticals (ARWR) United States $2.445B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.322B 18.45
Recursion Pharmaceuticals (RXRX) United States $1.962B 0.00
Soleno Therapeutics (SLNO) United States $1.910B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.789B 0.00
Xencor (XNCR) United States $1.579B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.576B 0.00
Ardelyx (ARDX) United States $1.566B 0.00
Harrow (HROW) United States $1.564B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.461B 0.00
ARS Pharmaceuticals (SPRY) United States $1.388B 0.00
Indivior (INDV) United States $1.384B 6.35
Cassava Sciences (SAVA) United States $1.367B 0.00
Ocular Therapeutix (OCUL) United States $1.353B 0.00
Evotec AG (EVO) Germany $1.265B 0.00
Collegium Pharmaceutical (COLL) United States $1.233B 7.07
Avadel Pharmaceuticals (AVDL) Ireland $1.227B 0.00
Enliven Therapeutics (ELVN) United States $1.140B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.041B 0.00
Relay Therapeutics (RLAY) United States $0.999B 0.00
Bioventus (BVS) United States $0.943B 30.63
Cronos Group (CRON) Canada $0.830B 0.00
USANA Health Sciences (USNA) United States $0.722B 13.26
Savara (SVRA) United States $0.698B 0.00
Pacira BioSciences (PCRX) United States $0.671B 6.35
Ironwood Pharmaceuticals (IRWD) United States $0.642B 40.20
Tourmaline Bio (TRML) United States $0.641B 0.00
Exscientia (EXAI) United Kingdom $0.612B 0.00
4D Molecular Therapeutics (FDMT) United States $0.563B 0.00
Silence Therapeutics (SLN) United Kingdom $0.546B 0.00
ProKidney (PROK) United States $0.539B 0.00
KalVista Pharmaceuticals (KALV) United States $0.533B 0.00
Foghorn Therapeutics (FHTX) United States $0.518B 0.00
OmniAb (OABI) United States $0.502B 0.00
Siga Technologies (SIGA) United States $0.497B 5.95
Altimmune (ALT) United States $0.460B 0.00
Sage Therapeutics (SAGE) United States $0.445B 0.00
Aquestive Therapeutics (AQST) United States $0.430B 0.00
Xeris Biopharma Holdings (XERS) United States $0.428B 0.00
Verve Therapeutics (VERV) United States $0.421B 0.00
Larimar Therapeutics (LRMR) United States $0.419B 0.00
Elite Pharmaceuticals (ELTP) United States $0.417B 39.00
Theravance Biopharma (TBPH) Cayman Islands $0.396B 0.00
Lyell Immunopharma (LYEL) United States $0.387B 0.00
Organogenesis (ORGO) United States $0.383B 0.00
Zevra Therapeutics (ZVRA) United States $0.364B 0.00
Eliem Therapeutics (ELYM) United States $0.334B 0.00
Esperion Therapeutics (ESPR) United States $0.330B 0.00
Aldeyra Therapeutics (ALDX) United States $0.327B 0.00
Korro Bio (KRRO) United States $0.321B 0.00
Heron Therapeutics (HRTX) United States $0.302B 0.00
Lexeo Therapeutics (LXEO) United States $0.301B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.289B 0.00
ESSA Pharma (EPIX) Canada $0.286B 0.00
Akebia Therapeutics (AKBA) United States $0.280B 0.00
Avita Medical (RCEL) United States $0.279B 0.00
Nature's Sunshine Products (NATR) United States $0.260B 17.77
Corbus Pharmaceuticals Holdings (CRBP) United States $0.252B 0.00
Nanobiotix S.A (NBTX) France $0.251B 0.00
Black Diamond Therapeutics (BDTX) United States $0.239B 0.00
Acrivon Therapeutics (ACRV) United States $0.222B 0.00
Nektar Therapeutics (NKTR) United States $0.215B 0.00
Pyxis Oncology (PYXS) United States $0.215B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.213B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.210B 0.00
Telomir Pharmaceuticals (TELO) United States $0.202B 0.00
CytoDyn (CYDY) United States $0.196B 0.00
Profound Medical (PROF) Canada $0.194B 0.00
MediWound (MDWD) Israel $0.190B 0.00
Innate Pharma SA (IPHYF) France $0.180B 0.00
Galectin Therapeutics (GALT) United States $0.169B 0.00
Achieve Life Sciences (ACHV) Canada $0.164B 0.00
VAXART, INC (VXRT) United States $0.146B 0.00
Cardiol Therapeutics (CRDL) Canada $0.145B 0.00
Context Therapeutics (CNTX) United States $0.140B 0.00
Century Therapeutics (IPSC) United States $0.136B 0.00
Incannex Healthcare (IXHL) Australia $0.128B 0.00
Fractyl Health (GUTS) United States $0.123B 0.00
Journey Medical (DERM) United States $0.119B 0.00
Prelude Therapeutics (PRLD) United States $0.117B 0.00
Assertio Holdings (ASRT) United States $0.113B 19.67
Regulus Therapeutics (RGLS) United States $0.105B 0.00
OptiNose (OPTN) United States $0.105B 0.00
Relmada Therapeutics (RLMD) United States $0.102B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.101B 0.00
Citius Pharmaceuticals (CTXR) United States $0.094B 0.00
CASI Pharmaceuticals (CASI) China $0.093B 0.00
AlloVir (ALVR) United States $0.092B 0.00
Karyopharm Therapeutics (KPTI) United States $0.090B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Metagenomi (MGX) United States $0.083B 0.00
PMV Pharmaceuticals (PMVP) United States $0.077B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 370.33
Verrica Pharmaceuticals (VRCA) United States $0.072B 0.00
Nutriband (NTRB) United States $0.067B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
Mural Oncology (MURA) Ireland $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
ProPhase Labs (PRPH) United States $0.046B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
Inotiv (NOTV) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
FibroGen (FGEN) United States $0.041B 0.00
DURECT (DRRX) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
Unicycive Therapeutics (UNCY) United States $0.039B 0.00
Protara Therapeutics (TARA) United States $0.039B 0.00
Enlivex Therapeutics (ENLV) Israel $0.035B 0.00
Tempest Therapeutics (TPST) United States $0.035B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Oruka Therapeutics (ORKA) United States $0.028B 0.00
VYNE Therapeutics (VYNE) United States $0.027B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
Lipocine (LPCN) United States $0.024B 0.00
MEI Pharma (MEIP) United States $0.019B 0.67
TherapeuticsMD (TXMD) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.019B 0.00
NRx Pharmaceuticals (NRXP) United States $0.019B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Talphera (TLPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Indaptus Therapeutics (INDP) United States $0.013B 0.00
Conduit Pharmaceuticals (CDT) United States $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
TransCode Therapeutics (RNAZ) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.010B 0.00
Aptorum Group (APM) United Kingdom $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
BioVie (BIVI) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Traws Pharma (TRAW) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.29
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 39.50